Combining genetic proxies of drug targets and time-to-event analyses from longitudinal observational data to identify target patient populations

Combining genetic proxies of drug targets and time-to-event analyses from longitudinal observational data to identify target patient populations

Abstract Background Human genetics is an important tool for identifying genes as potential drug targets, and the extensive genetic study of cardiovascular disease provides an opportunity to leverage genetics to match specific patient populations to specific drug targets to improve prioritization of...

Full description

Saved in:
Bibliographic Details
Main Authors: Luke Zhang, Prachi Kulkarni, Farshad Farshidfar, Whit Tingley, Tim Hoey, Whedy Wang, James R. Priest, Sylwia M. Figarska
Format: Article
Language:English
Published: BMC 2025-05-01
Series:BMC Cardiovascular Disorders
Subjects:
Drug target discovery
Patients selection
in silico trials
Cardiovascular outcomes
Online Access:https://doi.org/10.1186/s12872-025-04753-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12872-025-04753-1

Similar Items